Sesen Bio, Inc.
SESNNASDAQHealthcare
$0.63
+$0.04(+7.29%)
Market Cap$127955770
P/E Ratio—
52W High$0.965
52W Low$0.365
Sesen Bio, Inc. (SESN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SESN · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.04B | $0.03B | $0.01B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.04B | $0.03B | $0.01B | $0.00B |
| Gross Margin %(computed) | — | 100.00% | 100.00% | 100.00% | — |
| Operating Expenses | |||||
| R&D Expenses | $0.06B | $0.04B | $0.03B | $0.03B | $0.02B |
| G&A Expenses | $0.02B | $0.04B | $0.03B | $0.01B | $0.01B |
| Total Operating Expenses | $0.08B | $0.08B | $0.05B | $0.04B | $0.04B |
| Operating Income | $0.00B | ($0.03B) | ($0.01B) | ($0.02B) | ($0.11B) |
| Operating Margin %(computed) | — | -64.77% | -32.21% | -187.58% | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.06B) | ($0.02B) | ($0.01B) | ($0.02B) | ($0.11B) |
| Income Tax Expense | $0.00B | ($0.00B) | ($0.01B) | $0.00B | $0.07B |
| Net Income | ($0.06B) | ($0.02B) | ($0.00B) | ($0.02B) | ($0.18B) |
| Net Margin %(computed) | — | -49.71% | -1.27% | -199.33% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.46 | $-1.99 | $-0.04 | $-3.79 | $-39.40 |
| Wtd Avg Shares | 0.04B | 0.01B | 0.01B | 0.01B | 0.00B |
| EBITDA | $0.00B | ($0.05B) | ($0.01B) | ($0.02B) | $0.03B |
| EBITDA Margin %(computed) | — | -127.10% | -32.21% | -187.58% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Sesen Bio, Inc. data
About Sesen Bio, Inc. (SESN) Income Statement
Sesen Bio, Inc. (SESN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, SESN reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.06B) — a net profit margin of —.
Frequently asked questions
SESN · 4 questionsSesen Bio, Inc. (SESN) reported revenue of $0.00B for 2024, down 100.0% year-over-year.
SESN revenueSESN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09